Auctus Biologics is a biotechnology company that develops antibody mimetics for therapeutic and diagnostic applications.
Auctus Biologics has raised $229K in total funding. The most recent round was Grant. The last funding was announced in February 2022.
Auctus Biologics's investors include National Science Foundation, Grapeseed.Bio, Dennis Sanche.
Auctus Biologics is headquartered in Lafayette, United States.
Auctus Biologics is a biotechnology company that develops antibody mimetics for therapeutic and diagnostic applications.
Auctus Biologics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Auctus Biologics — Funding & Investors." VCBacked, February 9, 2022, https://www.vcbacked.co/company/auctus-biologics. Accessed August 14, 2026.
VCBacked. (2022). Auctus Biologics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/auctus-biologics
{{cite web |title=Auctus Biologics — Funding & Investors |url=https://www.vcbacked.co/company/auctus-biologics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated